StockWatch
·
Pharmaceuticals
Management Change29 May 2026, 02:00 pm

Ipca Labs Re-appoints Prashant Godha as Executive Director

AI Summary

Ipca Laboratories Ltd's Board of Directors has approved the re-appointment of Mr. Prashant Godha as Executive Director for a further period of 5 years, effective from August 16, 2026. This re-appointment is subject to shareholder approval at the upcoming Annual General Meeting. The board also approved the audited financial results for the year ended March 31, 2026, and recommended a dividend of ₹6 per share.

Key Highlights

  • Prashant Godha re-appointed as Executive Director for 5 years from August 16, 2026.
  • Re-appointment is subject to shareholder approval at the next AGM.
  • Board recommends a dividend of ₹6 per share for FY26.
  • Record date for dividend entitlement is fixed as August 7, 2026, subject to approval.